Ing Groep Nv Teva Pharmaceutical Industries LTD Transaction History

Ing Groep Nv

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$8.36 - $11.37 $13,376 - $18,192	1,600 New	1,600 $14,000
Q3 2019 Nov 08, 2019	SELL	$6.16 - $9.6 $286,255 - $446,112	-46,470 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$8.12 - $15.72 $190,819 - $369,420	23,500 Added 102.31%	46,470 $429,000
Q1 2019 May 13, 2019	BUY	$15.58 - $20.01 $62,320 - $80,040	4,000 Added 21.09%	22,970 $360,000
Q4 2018 Feb 13, 2019	SELL	$14.59 - $23.84 $65,655 - $107,280	-4,500 Reduced 19.17%	18,970 $293,000
Q3 2018 Nov 06, 2018	BUY	$21.06 - $25.65 $145,103 - $176,728	6,890 Added 41.56%	23,470 $506,000
Q2 2018 Aug 10, 2018	BUY	$16.77 - $24.71 $100,620 - $148,260	6,000 Added 56.71%	16,580 $403,000
Q1 2018 May 07, 2018	SELL	$16.68 - $22.07 $188,484 - $249,391	-11,300 Reduced 51.65%	10,580 $181,000
Q4 2017 Feb 06, 2018	SELL	$11.23 - $19.1 $35,374 - $60,165	-3,150 Reduced 12.58%	21,880 $415,000
Q3 2017 Nov 08, 2017	BUY	$15.41 - $32.17 $385,712 - $805,215	25,030	25,030 $441,000

671

571M

21.1M

9.94M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $18B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Ing Groep Nv, based on Form 13F filings with the SEC.

Stay updated on Ing Groep Nv with notifications on news.